Literature DB >> 3871251

In vivo sensitivity test in otitis media: efficacy of antibiotics.

V M Howie, R Dillard, B Lawrence.   

Abstract

During a 10-year period, antibiotics were assigned in random, double-blind fashion in six combinations to treat 948 episodes of otitis media in children. Exudate from the middle ear of all patients was cultured before treatment. Three follow-up visits were conducted; the first follow-up visit was three to five days after the start of therapy, and the second and third visits were 14 and 31 days after onset of treatment. Exudates were recultured for 75% of the patients on the first follow-up visit. Comparison of treatment results showed that triple sulfonamide combined with either phenoxymethyl penicillin, or benzathine and procaine penicillin G given intramuscularly (IM) was as effective as was ampicillin or amoxicillin. Phenoxymethyl penicillin and cyclacillin alone were usually effective against pneumococci but relatively ineffective against Haemophilus influenzae. Cefaclor and trimethoprim-sulfamethoxazole produced unsatisfactory results in about half the cases caused by pneumococci or H influenzae. Although production of beta-lactamase by some otitis-causing Haemophilus and Staphylococcus species may explain the ineffectiveness of some treatments, the percentage of organisms positive for beta-lactamase was too small to be responsible for the poor results with certain drugs.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3871251

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  10 in total

1.  Serum intercellular adhesion molecule 1 variations in young children with acute otitis media.

Authors:  Keyi Liu; Janet Casey; Michael Pichichero
Journal:  Clin Vaccine Immunol       Date:  2010-10-06

2.  Eradication by ceftriaxone of Streptococcus pneumoniae isolates with increased resistance to penicillin in cases of acute otitis media.

Authors:  P Gehanno; L Nguyen; B Barry; M Derriennic; F Pichon; J M Goehrs; P Berche
Journal:  Antimicrob Agents Chemother       Date:  1999-01       Impact factor: 5.191

3.  Can the choice of antibiotics for therapy of acute otitis media be logical?

Authors:  R Dagan
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-01       Impact factor: 3.267

4.  Amoxicillin treatment of experimental acute otitis media caused by Haemophilus influenzae with non-beta-lactamase-mediated resistance to beta-lactams: aspects of virulence and treatment.

Authors:  A Melhus; H Janson; E Westman; A Hermansson; A Forsgren; K Prellner
Journal:  Antimicrob Agents Chemother       Date:  1997-09       Impact factor: 5.191

5.  Expression of cytokine genes during pneumococcal and nontypeable Haemophilus influenzae acute otitis media in the rat.

Authors:  A Melhus; A F Ryan
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

6.  Bacteriologic efficacies of oral azithromycin and oral cefaclor in treatment of acute otitis media in infants and young children.

Authors:  R Dagan; E Leibovitz; D M Fliss; A Leiberman; M R Jacobs; W Craig; P Yagupsky
Journal:  Antimicrob Agents Chemother       Date:  2000-01       Impact factor: 5.191

7.  The Red Ear-drum: To Treat or Not To Treat?

Authors:  C D Marchant
Journal:  Can Fam Physician       Date:  1989-09       Impact factor: 3.275

8.  Dose Rationale for Amoxicillin in Neonatal Sepsis When Referral Is Not Possible.

Authors:  Salvatore D'Agate; Flora Tshinanu Musuamba; Oscar Della Pasqua
Journal:  Front Pharmacol       Date:  2020-09-25       Impact factor: 5.810

Review 9.  Acute otitis media in children: association with day care centers--antibacterial resistance, treatment, and prevention.

Authors:  David Greenberg; Sigalit Hoffman; Eugene Leibovitz; Ron Dagan
Journal:  Paediatr Drugs       Date:  2008       Impact factor: 3.022

Review 10.  Antibiotic resistance in Haemophilus influenzae: mechanisms, clinical importance and consequences for therapy.

Authors:  R de Groot; G Dzoljic-Danilovic; B van Klingeren; W H Goessens; H J Neyens
Journal:  Eur J Pediatr       Date:  1991-06       Impact factor: 3.183

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.